National Institute on Drug Abuse Publications ( 187 ) Collins LM. Murphy SA. Strecher V. The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions. 2007 May. Am J Prev Med. 32(5 Suppl):S112-8. National Institute on Drug Abuse National Cancer Institute St Pierre TL. Osgood DW. Siennick SE. Kauh TJ. Burden FF. Project ALERT with outside leaders: what leader characteristics are important for success? 2007 Mar. Prev Sci. 8(1):51-64. National Institute on Drug Abuse Dominak LM. Keating CD. Polymer encapsulation within giant lipid vesicles. 2007 Jun 19. Langmuir. 23(13):7148-54. National Institute on Drug Abuse National Institute of Child Health and Human Development Wang G. Myers C. Mikerov A. Floros J. Effect of cysteine 85 on biochemical properties and biological function of human surfactant protein A variants. 2007 Jul 17. Biochemistry. 46(28):8425-35. National Institute for Biomedical Imaging and Bioengineering National Institute on Drug Abuse National Heart, Lung, and Blood Institute Carmichael OT. Kuller LH. Lopez OL. Thompson PM. Dutton RA. Lu A. Lee SE. Lee JY. Aizenstein HJ. Meltzer CC. Liu Y. Toga AW. Becker JT. Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia. 2007 Jan-Mar. Alzheimer Dis Assoc Disord. 21(1):14-24. National Institute on Aging National Institute on Drug Abuse National Institute for Biomedical Imaging and Bioengineering National Institute of Mental Health National Heart, Lung, and Blood Institute National Institute of Neurological Disorders and Stroke National Center for Research Resources Feinberg ME. Button TM. Neiderhiser JM. Reiss D. Hetherington EM. Parenting and adolescent antisocial behavior and depression: evidence of genotype x parenting environment interaction. 2007 Apr. Arch Gen Psychiatry. 64(4):457-65. National Institute on Drug Abuse National Institute of Child Health and Human Development National Institute of Mental Health Cortese BM. Moore GJ. Bailey BA. Jacobson SW. Delaney-Black V. Hannigan JH. Magnetic resonance and spectroscopic imaging in prenatal alcohol-exposed children: preliminary findings in the caudate nucleus. 2006 Sep-Oct. Neurotoxicol Teratol. 28(5):597-606. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Freet CS. Tesche JD. Tompers DM. Riegel KE. Grigson PS. Lewis rats are more sensitive than Fischer rats to successive negative contrast, but less sensitive to the anxiolytic and appetite-stimulating effects of chlordiazepoxide. 2006 Oct. Pharmacol Biochem Behav. 85(2):378-84. National Institute on Drug Abuse Palen LA. Smith EA. Flisher AJ. Caldwell LL. Mpofu E. Substance use and sexual risk behavior among South African eighth grade students. 2006 Nov. J Adolesc Health. 39(5):761-3. National Institute on Drug Abuse Freeman WM. Gooch RS. Lull ME. Worst TJ. Walker SJ. Xu AS. Green H. Pierre PJ. Grant KA. Vrana KE. Apo-AII is an elevated biomarker of chronic non-human primate ethanol self-administration. 2006 May-Jun. Alcohol Alcohol. 41(3):300-5. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Freeman WM. Lull ME. Guilford MT. Vrana KE. Depletion of abundant proteins from non-human primate serum for biomarker studies. 2006 May. Proteomics. 6(10):3109-13. National Institute on Drug Abuse van Rossum DB. Patterson RL. Cheung KH. Barrow RK. Syrovatkina V. Gessell GS. Burkholder SG. Watkins DN. Foskett JK. Snyder SH. DANGER, a novel regulatory protein of inositol 1,4,5-trisphosphate-receptor activity. 2006 Dec 1. J Biol Chem. 281(48):37111-6. National Institute on Drug Abuse National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health Graham JW. Taylor BJ. Olchowski AE. Cumsille PE. Planned missing data designs in psychological research. 2006 Dec. Psychol Methods. 11(4):323-43. National Institute on Drug Abuse Finnegan TF. Chen SR. Pan HL. Mu opioid receptor activation inhibits GABAergic inputs to basolateral amygdala neurons through Kv1.1/1.2 channels. 2006 Apr. J Neurophysiol. 95(4):2032-41. National Institute on Drug Abuse National Institute of General Medical Sciences National Institute of Neurological Disorders and Stroke Bustillo J. Barrow R. Paz R. Tang J. Seraji-Bozorgzad N. Moore GJ. Bolognani F. Lauriello J. Perrone-Bizzozero N. Galloway MP. Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels. 2006 Apr. Neuropsychopharmacology. 31(4):751-6. National Institute on Drug Abuse Collins LM. Analysis of longitudinal data: the integration of theoretical model, temporal design, and statistical model. 2006. Annu Rev Psychol. 57:505-28. National Institute on Drug Abuse Chung H. Park Y. Lanza ST. Latent transition analysis with covariates: pubertal timing and substance use behaviours in adolescent females. 2005 Sep 30. Stat Med. 24(18):2895-910. National Institute on Drug Abuse Ridenour TA. Maldonado-Molina M. Compton WM. Spitznagel EL. Cottler LB. Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability. 2005 Oct 1. Drug Alcohol Depend. 80(1):1-14. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institute of Mental Health Wells R. Lemak CH. D'Aunno TA. Factors associated with interorganizational relationships among outpatient drug treatment organizations 1990-2000. 2005 Oct. Health Serv Res. 40(5 Pt 1):1356-78. National Institute on Drug Abuse Collins RT. Liu Y. Leordeanu M. Online selection of discriminative tracking features. 2005 Oct. IEEE Trans Pattern Anal Mach Intell. 27(10):1631-43. National Institute on Aging National Institute on Drug Abuse National Cancer Institute Lanza ST. Collins LM. Schafer JL. Flaherty BP. Using data augmentation to obtain standard errors and conduct hypothesis tests in latent class and latent transition analysis. 2005 Mar. Psychol Methods. 10(1):84-100. National Institute on Drug Abuse Liu C. Grigson PS. Brief access to sweets protect against relapse to cocaine-seeking. 2005 Jul 5. Brain Res. 1049(1):128-31. National Institute on Drug Abuse Finnegan TF. Chen SR. Pan HL. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala. 2005 Feb. J Pharmacol Exp Ther. 312(2):441-8. National Institute on Drug Abuse National Institute of General Medical Sciences National Institute of Neurological Disorders and Stroke Liu C. Sue Grigson P. Mu opioid receptor agonist DAMGO-induced suppression of saccharin intake in Lewis and Fischer rats. 2005 Dec 7. Brain Res. 1064(1-2):155-60. National Institute on Drug Abuse Wells R. Lemak CH. D'Aunno TA. Organizational survival in the outpatient substance abuse treatment sector, 1988-2000. 2005 Dec. Med Care Res Rev. 62(6):697-719. National Institute on Drug Abuse St Pierre TL. Osgood DW. Mincemoyer CC. Kaltreider DL. Kauh TJ. Results of an independent evaluation of Project ALERT delivered in schools by Cooperative Extension. 2005 Dec. Prev Sci. 6(4):305-17. National Institute on Drug Abuse Patterson RL. van Rossum DB. Nikolaidis N. Gill DL. Snyder SH. Phospholipase C-gamma: diverse roles in receptor-mediated calcium signaling. 2005 Dec. Trends Biochem Sci. 30(12):688-97. National Institute on Drug Abuse National Heart, Lung, and Blood Institute National Institute of Mental Health Collins LM. Murphy SA. Nair VN. Strecher VJ. A strategy for optimizing and evaluating behavioral interventions. 2005 Aug. Ann Behav Med. 30(1):65-73. National Institute on Drug Abuse National Cancer Institute Schroy PL. Wheeler RA. Davidson C. Scalera G. Twining RC. Grigson PS. Role of gustatory thalamus in anticipation and comparison of rewards over time in rats. 2005 Apr. Am J Physiol Regul Integr Comp Physiol. 288(4):R966-80. National Institute on Drug Abuse Maggs JL. Schulenberg JE. Initiation and course of alcohol consumption among adolescents and young adults. 2005. Recent Dev Alcohol. 17:29-47. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institute of Mental Health Freeman WM. Brebner K. Amara SG. Reed MS. Pohl J. Phillips AG. Distinct proteomic profiles of amphetamine self-administration transitional states. 2005. Pharmacogenomics J. 5(3):203-14. National Institute on Drug Abuse Collins LM. Murphy SA. Bierman KL. A conceptual framework for adaptive preventive interventions. 2004 Sep. Prev Sci. 5(3):185-96. National Institute on Drug Abuse Klein LC. Stine MM. Vandenbergh DJ. Whetzel CA. Kamens HM. Sex differences in voluntary oral nicotine consumption by adolescent mice: a dose-response experiment. 2004 May. Pharmacol Biochem Behav. 78(1):13-25. National Institute on Drug Abuse Greenberg MT. Current and future challenges in school-based prevention: the researcher perspective. 2004 Mar. Prev Sci. 5(1):5-13. National Institute on Drug Abuse National Institute of Mental Health King G. Flisher AJ. Noubary F. Reece R. Marais A. Lombard C. Substance abuse and behavioral correlates of sexual assault among South African adolescents. 2004 Jun. Child Abuse Negl. 28(6):683-96. Fogarty International Center National Institute on Drug Abuse Lanza ST. Donny EC. Collins LM. Balster RL. Analyzing the acquisition of drug self-administration using growth curve models. 2004 Jul 15. Drug Alcohol Depend. 75(1):11-21. National Cancer Institute National Institute on Drug Abuse Klein LC. Corwin EJ. Ceballos RM. Leptin, hunger, and body weight: Influence of gender, tobacco smoking, and smoking abstinence. 2004 Jul. Addict Behav. 29(5):921-7. National Institute on Drug Abuse National Center for Research Resources Ridenour TA. Cottler LB. Compton WM. Spitznagel EL. Cunningham-Williams RM. Is there a progression from abuse disorders to dependence disorders? 2003 May. Addiction. 98(5):635-44. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institute of Mental Health Blizard DA. Klein LC. Cohen R. McClearn GE. A novel mouse-friendly cognitive task suitable for use in aging studies. 2003 Mar. Behav Genet. 33(2):181-9. National Institute on Aging National Institute on Drug Abuse Ridenour TA. Treloar JH. Dean RS. Utility analysis for clinical decision-making in small treatment settings. 2003 Mar. Int J Neurosci. 113(3):417-30. National Institute on Drug Abuse National Institute of Mental Health Posse S. Fitzgerald D. Gao K. Habel U. Rosenberg D. Moore GJ. Schneider F. Real-time fMRI of temporolimbic regions detects amygdala activation during single-trial self-induced sadness. 2003 Mar. Neuroimage. 18(3):760-8. National Institute on Drug Abuse Public Health Service National Institute of Mental Health Vrana KE. Freeman WM. Aschner M. Use of microarray technologies in toxicology research. 2003 Jun. Neurotoxicology. 24(3):321-32. National Institute on Drug Abuse Agency for Health Care Policy and Research Corwin EJ. Klein LC. C-reactive protein and depressed mood in a sub-group of smokers during nicotine abstinence. 2003 Jul. Hum Psychopharmacol. 18(5):329-37. National Institute on Drug Abuse National Center for Research Resources Klein LC. Stine MM. Pfaff DW. Vandenbergh DJ. Laternal nicotine exposure increases nicotine preference in periadolescent male but not female C57B1/6J mice. 2003 Feb. Nicotine Tob Res. 5(1):117-24. National Institute on Drug Abuse Hecht ML. Marsiglia FF. Elek E. Wagstaff DA. Kulis S. Dustman P. Miller-Day M. Culturally grounded substance use prevention: an evaluation of the keepin' it R.E.A.L. curriculum. 2003 Dec. Prev Sci. 4(4):233-48. National Institute on Drug Abuse Demirtas H. Schafer JL. On the performance of random-coefficient pattern-mixture models for non-ignorable drop-out. 2003 Aug 30. Stat Med. 22(16):2553-75. National Institute on Drug Abuse O'Connor RJ. Flaherty BP. Quinio Edwards B. Kozlowski LT. Regular smokeless tobacco use is not a reliable predictor of smoking onset when psychosocial predictors are included in the model. 2003 Aug. Nicotine Tob Res. 5(4):535-43. National Institute on Drug Abuse Nyland SB. Cao C. Bai Y. Loughran TP. Ugen KE. Modulation of infection and type 1 cytokine expression parameters by morphine during in vitro coinfection with human T-cell leukemia virus type I and HIV-1. 2003 Apr 1. J Acquir Immune Defic Syndr. 32(4):406-16. National Institute on Drug Abuse Worst TJ. Freeman WM. Walker SJ. Vrana KE. Systematic screening of gene expression using a cDNA macroarray. 2003. Methods Mol Med. 79:243-59. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Stine MM. O'Connor RJ. Yatko BR. Grunberg NE. Klein LC. Evidence for a relationship between daily caffeine consumption and accuracy of time estimation. 2002 Oct. Hum Psychopharmacol. 17(7):361-7. National Institute on Drug Abuse Freeman WM. Brebner K. Patel KM. Lynch WJ. Roberts DC. Vrana KE. Repeated cocaine self-administration causes multiple changes in rat frontal cortex gene expression. 2002 Oct. Neurochem Res. 27(10):1181-92. National Institute on Drug Abuse Collins LM. Graham JW. The effect of the timing and spacing of observations in longitudinal studies of tobacco and other drug use: temporal design considerations. 2002 Nov. Drug Alcohol Depend. 68 Suppl 1:S85-96. National Institute on Drug Abuse Thompson SK. Collins LM. Adaptive sampling in research on risk-related behaviors. 2002 Nov. Drug Alcohol Depend. 68 Suppl 1:S57-67. Public Health Service National Institute on Drug Abuse Flaherty BP. Assessing reliability of categorical substance use measures with latent class analysis. 2002 Nov. Drug Alcohol Depend. 68 Suppl 1:S7-20. National Institute on Drug Abuse Jones BC. Wheeler DS. Beard JL. Grigson PS. Iron deficiency in rats decreases acquisition of and suppresses responding for cocaine. 2002 Nov. Pharmacol Biochem Behav. 73(4):813-9. National Institute on Drug Abuse National Institute of Child Health and Human Development National Institute of Neurological Disorders and Stroke Haycock JW. Kumer SC. Lewis DA. Vrana KE. Stockmeier CA. A monoclonal antibody to tryptophan hydroxylase: applications and identification of the epitope. 2002 Mar 15. J Neurosci Methods. 114(2):205-12. National Institute of Mental Health National Institute of General Medical Sciences National Institute of Neurological Disorders and Stroke National Institute on Drug Abuse Lanza ST. Collins LM. Pubertal timing and the onset of substance use in females during early adolescence. 2002 Mar. Prev Sci. 3(1):69-82. National Institute on Drug Abuse Schafer JL. Graham JW. Missing data: our view of the state of the art. 2002 Jun. Psychol Methods. 7(2):147-77. National Institute on Drug Abuse Freeman WM. Brebner K. Lynch WJ. Patel KM. Robertson DJ. Roberts DC. Vrana KE. Changes in rat frontal cortex gene expression following chronic cocaine. 2002 Jul 15. Brain Res Mol Brain Res. 104(1):11-20. National Institute on Drug Abuse Grigson PS. Like drugs for chocolate: separate rewards modulated by common mechanisms? 2002 Jul. Physiol Behav. 76(3):389-95. National Institute on Drug Abuse Maples JJ. Murphy SA. Axinn WG. Two-level proportional hazards models. 2002 Dec. Biometrics. 58(4):754-63. National Institute on Drug Abuse National Institute of Child Health and Human Development Henry KL. Smith EA. Hopkins AM. The effect of active parental consent on the ability to generalize the results of an alcohol, tobacco, and other drug prevention trial to rural adolescents. 2002 Dec. Eval Rev. 26(6):645-55. National Institute on Drug Abuse Palmer RF. Graham JW. Taylor B. Tatterson J. Construct validity in health behavior research: interpreting latent variable models involving self-report and objective measures. 2002 Dec. J Behav Med. 25(6):525-50. National Institute on Drug Abuse Stokes AH. Freeman WM. Mitchell SG. Burnette TA. Hellmann GM. Vrana KE. Induction of GADD45 and GADD153 in neuroblastoma cells by dopamine-induced toxicity. 2002 Dec. Neurotoxicology. 23(6):675-84. National Institute on Drug Abuse National Institute of General Medical Sciences Grigson PS. Twining RC. Cocaine-induced suppression of saccharin intake: a model of drug-induced devaluation of natural rewards. 2002 Apr. Behav Neurosci. 116(2):321-33. National Institute on Drug Abuse National Institute on Deafness and other Communication Disorders Graham JW. Roberts MM. Tatterson JW. Johnston SE. Data quality in evaluation of an alcohol-related harm prevention program. 2002 Apr. Eval Rev. 26(2):147-89. National Institute on Drug Abuse Grigson PS. Cornelius K. Wheeler DS. The suppressive effects of intraperitoneal cocaine are augmented when evaluated in nondeprived rats. 2001 May-Jun. Pharmacol Biochem Behav. 69(1-2):117-23. National Institute on Drug Abuse Sorg BA. Tschirgi ML. Swindell S. Chen L. Fang J. Repeated formaldehyde effects in an animal model for multiple chemical sensitivity. 2001 Mar. Ann N Y Acad Sci. 933:57-67. National Institute on Drug Abuse National Institute of Environmental Health Sciences Reed CL. Hood KE. Cortes DA. Jones BC. Genetic-environment analysis of sensitivity and acute tolerance to ethanol in mice. 2001 Jul-Aug. Pharmacol Biochem Behav. 69(3-4):461-7. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Collins LM. Schafer JL. Kam CM. A comparison of inclusive and restrictive strategies in modern missing data procedures. 2001 Dec. Psychol Methods. 6(4):330-51. National Institute on Drug Abuse Grigson PS. Wheeler RA. Wheeler DS. Ballard SM. Chronic morphine treatment exaggerates the suppressive effects of sucrose and cocaine, but not lithium chloride, on saccharin intake in Sprague-Dawley rats. 2001 Apr. Behav Neurosci. 115(2):403-16. National Institute on Drug Abuse National Institute on Deafness and other Communication Disorders Freeman WM. Nader MA. Nader SH. Robertson DJ. Gioia L. Mitchell SM. Daunais JB. Porrino LJ. Friedman DP. Vrana KE. Chronic cocaine-mediated changes in non-human primate nucleus accumbens gene expression. 2001 Apr. J Neurochem. 77(2):542-9. National Institute on Drug Abuse Nyland SB. Specter S. Ugen KE. Direct vs. indirect modulation of complex in vitro human retroviral infections by morphine. 2001. Adv Exp Med Biol. 493:49-58. National Institute on Drug Abuse Freeman WM. Brebner K. Lynch WJ. Robertson DJ. Roberts DC. Vrana KE. Cocaine-responsive gene expression changes in rat hippocampus. 2001. Neuroscience. 108(3):371-80. National Institute on Drug Abuse Freeman WM. Robertson DJ. Vrana KE. Fundamentals of DNA hybridization arrays for gene expression analysis. 2000 Nov. Biotechniques. 29(5):1042-6, 1048-55. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Stokes AH. Xu Y. Daunais JA. Tamir H. Gershon MD. Butkerait P. Kayser B. Altman J. Beck W. Vrana KE. p-ethynylphenylalanine: a potent inhibitor of tryptophan hydroxylase. 2000 May. J Neurochem. 74(5):2067-73. National Institute of Diabetes and Digestive and Kidney Diseases National Institute of General Medical Sciences National Institute on Drug Abuse Stokes AH. Lewis DY. Lash LH. Jerome WG. Grant KW. Aschner M. Vrana KE. Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by L-BSO and apoptosis. 2000 Mar 6. Brain Res. 858(1):1-8. National Institute of General Medical Sciences National Institute on Drug Abuse Grigson PS. Lyuboslavsky P. Tanase D. Bilateral lesions of the gustatory thalamus disrupt morphine- but not LiCl-induced intake suppression in rats: evidence against the conditioned taste aversion hypothesis. 2000 Mar 10. Brain Res. 858(2):327-37. National Institute on Drug Abuse National Institute on Deafness and other Communication Disorders Cumsille PE. Sayer AG. Graham JW. Perceived exposure to peer and adult drinking as predictors of growth in positive alcohol expectancies during adolescence. 2000 Jun. J Consult Clin Psychol. 68(3):531-6. National Institute on Drug Abuse Grigson PS. Twining RC. Carelli RM. Heroin-induced suppression of saccharin intake in water-deprived and water-replete rats. 2000 Jul. Pharmacol Biochem Behav. 66(3):603-8. National Institute on Drug Abuse National Institute on Deafness and other Communication Disorders Freeman WM. Yohrling GJ. Daunais JB. Gioia L. Hart SL. Porrino LJ. Davies HM. Vrana KE. A cocaine analog, 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT), reduces tyrosine hydroxylase in the mesolimbic dopamine pathway. 2000 Dec 22. Drug Alcohol Depend. 61(1):15-21. National Institute on Drug Abuse Taylor BJ. Graham JW. Cumsille P. Hansen WB. Modeling prevention program effects on growth in substance use: analysis of five years of data from the Adolescent Alcohol Prevention Trial. 2000 Dec. Prev Sci. 1(4):183-97. National Institute on Drug Abuse Grigson PS. Drugs of abuse and reward comparison: a brief review. 2000 Aug. Appetite. 35(1):89-91. National Institute on Drug Abuse Gomez F. Leo NA. Grigson PS. Morphine-induced suppression of saccharin intake is correlated with elevated corticosterone levels. 2000 Apr 28. Brain Res. 863(1-2):52-8. National Institute on Drug Abuse National Institute on Deafness and other Communication Disorders Cappon GD. Pu C. Vorhees CV. Time-course of methamphetamine-induced neurotoxicity in rat caudate-putamen after single-dose treatment. 2000 Apr 28. Brain Res. 863(1-2):106-11. National Institute on Drug Abuse Grigson PS. Freet CS. The suppressive effects of sucrose and cocaine, but not lithium chloride, are greater in Lewis than in Fischer rats: evidence for the reward comparison hypothesis. 2000 Apr. Behav Neurosci. 114(2):353-63. National Institute on Drug Abuse National Institute on Deafness and other Communication Disorders Blackson TC. Butler T. Belsky J. Ammerman RT. Shaw DS. Tarter RE. Individual traits and family contexts predict sons' externalizing behavior and preliminary relative risk ratios for conduct disorder and substance use disorder outcomes. 1999 Sep 1. Drug Alcohol Depend. 56(2):115-31. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Gomez F. Grigson PS. The suppressive effects of LiCl, sucrose, and drugs of abuse are modulated by sucrose concentration in food-deprived rats. 1999 Sep. Physiol Behav. 67(3):351-7. National Institute on Drug Abuse National Institute on Deafness and other Communication Disorders Wagstaff DA. Delamater JD. Havens KK. Subsequent infection among adolescent African-American males attending a sexually transmitted disease clinic. 1999 Sep. J Adolesc Health. 25(3):217-26. National Institute on Drug Abuse National Institute of Mental Health Jones BC. Tarantino LM. Rodriguez LA. Reed CL. McClearn GE. Plomin R. Erwin VG. Quantitative-trait loci analysis of cocaine-related behaviours and neurochemistry. 1999 Oct. Pharmacogenetics. 9(5):607-17. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Letchworth SR. Sexton T. Childers SR. Vrana KE. Vaughan RA. Davies HM. Porrino LJ. Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration. 1999 Nov. J Neurochem. 73(5):1982-9. National Institute on Drug Abuse Stokes AH. Hastings TG. Vrana KE. Cytotoxic and genotoxic potential of dopamine. 1999 Mar 15. J Neurosci Res. 55(6):659-65. National Institute on Drug Abuse National Institute of Neurological Disorders and Stroke Schafer JL. Multiple imputation: a primer. 1999 Mar. Stat Methods Med Res. 8(1):3-15. National Institute on Drug Abuse National Cancer Institute Morse AC. Beard JL. Jones BC. A genetic developmental model of iron deficiency: biological aspects. 1999 Mar. Proc Soc Exp Biol Med. 220(3):147-52. National Institute on Drug Abuse Mark GP. Hajnal A. Kinney AE. Keys AS. Self-administration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats. 1999 Mar. Psychopharmacology (Berl). 143(1):47-53. National Institute on Drug Abuse Freeman WM. Walker SJ. Vrana KE. Quantitative RT-PCR: pitfalls and potential. 1999 Jan. Biotechniques. 26(1):112-22, 124-5. National Institute on Drug Abuse Grigson PS. Lyuboslavsky PN. Tanase D. Wheeler RA. Water-deprivation prevents morphine-, but not LiCl-induced, suppression of sucrose intake. 1999 Aug. Physiol Behav. 67(2):277-86. National Institute on Drug Abuse National Institute on Deafness and other Communication Disorders Cohen ED. An exploratory attempt to distinguish subgroups among crack-abusing African-American women. 1999. J Addict Dis. 18(3):41-54. National Institute on Drug Abuse Fukumura M. Cappon GD. Pu C. Broening HW. Vorhees CV. A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostriatal monoamines and glial fibrillary acidic protein. 1998 Sep 21. Brain Res. 806(1):1-7. National Institute on Drug Abuse Grigson PS. Reilly S. Scalera G. Norgren R. The parabrachial nucleus is essential for acquisition of a conditioned odor aversion in rats. 1998 Oct. Behav Neurosci. 112(5):1104-13. National Institute on Drug Abuse National Institute on Deafness and other Communication Disorders Palmer RF. Graham JW. White EL. Hansen WB. Applying multilevel analytic strategies in adolescent substance use prevention research. 1998 May-Jun. Prev Med. 27(3):328-36. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Loughran TP. Hadlock KG. Perzova R. Gentile TC. Yang Q. Foung SK. Poiesz BJ. Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia. 1998 May. Br J Haematol. 101(2):318-24. National Institute of Allergy and Infectious Diseases National Cancer Institute National Institute on Drug Abuse Azar MR. Acar N. Erwin VG. Barbato GF. Morse AC. Heist CL. Jones BC. Distribution and clearance of cocaine in brain is influenced by genetics. 1998 Mar. Pharmacol Biochem Behav. 59(3):637-40. National Institute on Drug Abuse Cook MN. Ware DD. Boone EM. Hou X. Morse AC. Reed CL. Erwin VG. Jones BC. Ethanol modulates cocaine-induced behavioral change in inbred mice. 1998 Mar. Pharmacol Biochem Behav. 59(3):567-75. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Jones BC. Sarrieau A. Reed CL. Azar MR. Mormède P. Contribution of sex and genetics to neuroendocrine adaptation to stress in mice. 1998 Jul. Psychoneuroendocrinology. 23(5):505-17. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse McClearn GE. Tarantino LM. Hofer SM. Jones B. Plomin R. Developmental loss of effect of a Chromosome 15 QTL on alcohol acceptance. 1998 Dec. Mamm Genome. 9(12):991-4. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Mets B. Winger G. Cabrera C. Seo S. Jamdar S. Yang G. Zhao K. Briscoe RJ. Almonte R. Woods JH. Landry DW. A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats. 1998 Aug 18. Proc Natl Acad Sci U S A. 95(17):10176-81. National Institute on Drug Abuse Tarantino LM. McClearn GE. Rodriguez LA. Plomin R. Confirmation of quantitative trait loci for alcohol preference in mice. 1998 Aug. Alcohol Clin Exp Res. 22(5):1099-105. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Gioia L. Vogt LJ. Freeman WM. Flood A. Vogt BA. Vrana KE. PCR-based apolipoprotein E genotype analysis from archival fixed brain. 1998 Apr 30. J Neurosci Methods. 80(2):209-14. National Institute on Aging National Institute on Drug Abuse National Institute of Mental Health Nyland SB. Specter S. Im-Sin J. Ugen KE. Opiate effects on in vitro human retroviral infection. 1998. Adv Exp Med Biol. 437:91-100. National Institute on Drug Abuse National Heart, Lung, and Blood Institute Noe SN. Nyland SB. Ugen K. Friedman H. Klein TW. Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-1MN. 1998. Adv Exp Med Biol. 437:223-9. National Institute on Drug Abuse Hajnal A. Mark GP. Keys AS. Lénárd L. Involvement of dopamine and acetylcholine in the interaction between amygdala and nucleus accumbens: chronic microdialysis in rats. 1998. Neurobiology (Bp). 6(3):363-7. National Institute on Drug Abuse Loughran TP. Hadlock KG. Yang Q. Perzova R. Zambello R. Semenzato G. Foung SK. Poiesz BJ. Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes. 1997 Sep 1. Blood. 90(5):1977-81. National Cancer Institute National Institute on Drug Abuse National Heart, Lung, and Blood Institute McClearn GE. Tarantino LM. Rodriguez LA. Jones BC. Blizard DA. Plomin R. Genotypic selection provides experimental confirmation for an alcohol consumption quantitative trait locus in mouse. 1997 Oct-Nov. Mol Psychiatry. 2(6):486-9. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Mockus SM. Kumer SC. Vrana KE. Carboxyl terminal deletion analysis of tryptophan hydroxylase. 1997 Oct 17. Biochim Biophys Acta. 1342(2):132-40. National Institute of General Medical Sciences National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Streufert S. Satish U. Pogash R. Gingrich D. Landis R. Roache J. Severs W. Excess coffee consumption in simulated complex work settings: detriment or facilitation of performance? 1997 Oct. J Appl Psychol. 82(5):774-82. National Institute on Drug Abuse Kumer SC. Mockus SM. Rucker PJ. Vrana KE. Amino-terminal analysis of tryptophan hydroxylase: protein kinase phosphorylation occurs at serine-58. 1997 Oct. J Neurochem. 69(4):1738-45. National Institute of General Medical Sciences National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Boone EM. Cook MN. Hou X. Jones BC. Sex and strain influence the effect of ethanol on central monoamines. 1997 Nov. J Stud Alcohol. 58(6):590-9. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Pillitteri JL. Kozlowski LT. Sweeney CT. Heatherton TF. Individual differences in the subjective effects of the first cigarette of the day: a self-report method for studying tolerance. 1997 Feb. Exp Clin Psychopharmacol. 5(1):83-90. National Institute on Drug Abuse Public Health Service Grigson PS. Conditioned taste aversions and drugs of abuse: a reinterpretation. 1997 Feb. Behav Neurosci. 111(1):129-36. National Institute on Drug Abuse National Institute on Deafness and other Communication Disorders Mockus SM. Kumer SC. Vrana KE. A chimeric tyrosine/tryptophan hydroxylase. The tyrosine hydroxylase regulatory domain serves to stabilize enzyme activity. 1997 Aug. J Mol Neurosci. 9(1):35-48. National Institute of General Medical Sciences National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Xu Y. Stokes AH. Freeman WM. Kumer SC. Vogt BA. Vrana KE. Tyrosinase mRNA is expressed in human substantia nigra. 1997 Apr. Brain Res Mol Brain Res. 45(1):159-62. National Institute on Aging National Institute of General Medical Sciences National Institute on Drug Abuse Keck BJ. Lakoski JM. Region-specific serotonin1A receptor turnover following irreversible blockade with EEDQ. 1996 Nov 4. Neuroreport. 7(15-17):2717-21. National Institute on Aging National Institute on Drug Abuse Freeman WM. Vrana SL. Vrana KE. Use of elevated reverse transcription reaction temperatures in RT-PCR. 1996 May. Biotechniques. 20(5):782-3. National Institute on Drug Abuse Virag L. Mets B. Jamdar S. Determination of cocaine, norcocaine, benzoylecgonine and ecgonine methyl ester in rat plasma by high-performance liquid chromatography with ultraviolet detection. 1996 Jun 7. J Chromatogr B Biomed Appl. 681(2):263-9. National Institute on Drug Abuse Keck J. Lakoski JM. Age-related assessment of central 5-HT1A receptors following irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). 1996 Jul 22. Brain Res. 728(1):130-4. National Institute on Drug Abuse National Institute on Aging Jones BC. Hou X. Cook MN. Effect of exposure to novelty on brain monoamines in C57BL/6 and DBA/2 mice. 1996 Feb. Physiol Behav. 59(2):361-7. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Kumer SC. Vrana KE. Intricate regulation of tyrosine hydroxylase activity and gene expression. 1996 Aug. J Neurochem. 67(2):443-62. National Institute on Drug Abuse National Institute of General Medical Sciences Pu C. Broening HW. Vorhees CV. Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex. 1996 Aug. Synapse. 23(4):328-34. National Institute on Drug Abuse National Institute of Environmental Health Sciences McClearn GE. Vogler GP. Plomin R. Genetics and behavioral medicine. 1996. Behav Med. 22(3):93-102. National Institute on Alcohol Abuse and Alcoholism National Institute on Aging National Institute on Drug Abuse Kluttz BW. Vrana KE. Dworkin SI. Childers SR. Effects of morphine on forskolin-stimulated pro-enkephalin mRNA levels in rat striatum: a model for acute and chronic opioid actions in brain. 1995 Sep. Brain Res Mol Brain Res. 32(2):313-20. National Institute on Drug Abuse Streufert S. Pogash R. Braig D. Gingrich D. Kantner A. Landis R. Lonardi L. Roache J. Severs W. Alcohol hangover and managerial effectiveness. 1995 Oct. Alcohol Clin Exp Res. 19(5):1141-6. National Institute on Drug Abuse Morse AC. Erwin VG. Jones BC. Behavioral responses to low doses of cocaine are affected by genetics and experimental history. 1995 Nov. Physiol Behav. 58(5):891-7. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Collins LM. Johnston MV. Analysis of stage-sequential change in rehabilitation research. 1995 Mar-Apr. Am J Phys Med Rehabil. 74(2):163-70. National Institute on Drug Abuse Pu C. Vorhees CV. Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: an immunohistochemical study. 1995 Feb. Synapse. 19(2):97-104. National Institute on Drug Abuse National Institute of Environmental Health Sciences Vrana SL. Kluttz BW. Vrana KE. Application of quantitative RT-PCR to the analysis of dopamine receptor mRNA levels in rat striatum. 1995 Dec 1. Brain Res Mol Brain Res. 34(1):127-34. National Institute on Drug Abuse Morse AC. Erwin VG. Jones BC. Pharmacogenetics of cocaine: a critical review. 1995 Aug. Pharmacogenetics. 5(4):183-92. National Institute on Drug Abuse Rodriguez LA. Plomin R. Blizard DA. Jones BC. McClearn GE. Alcohol acceptance, preference, and sensitivity in mice. II. Quantitative trait loci mapping analysis using BXD recombinant inbred strains. 1995 Apr. Alcohol Clin Exp Res. 19(2):367-73. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Streufert S. Pogash R. Miller J. Gingrich D. Landis R. Lonardi L. Severs W. Roache JD. Effects of caffeine deprivation on complex human functioning. 1995 Apr. Psychopharmacology (Berl). 118(4):377-84. National Institute on Drug Abuse Zhuang H. Patel SV. He TC. Niu Z. Wojchowski DM. Dominant negative effects of a carboxy-truncated Jak2 mutant on Epo-induced proliferation and Jak2 activation. 1994 Oct 14. Biochem Biophys Res Commun. 204(1):278-83. National Institute of Diabetes and Digestive and Kidney Diseases National Heart, Lung, and Blood Institute National Institute on Drug Abuse Streufert S. Pogash R. Roache J. Severs W. Gingrich D. Landis R. Lonardi L. Kantner A. Alcohol and managerial performance. 1994 Mar. J Stud Alcohol. 55(2):230-8. National Institute on Drug Abuse Pu C. Fisher JE. Cappon GD. Vorhees CV. The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum. 1994 Jun 27. Brain Res. 649(1-2):217-24. National Institute on Drug Abuse National Institute of Environmental Health Sciences Rodriguez LA. Plomin R. Blizard DA. Jones BC. McClearn GE. Alcohol acceptance, preference, and sensitivity in mice. I. Quantitative genetic analysis using BXD recombinant inbred strains. 1994 Dec. Alcohol Clin Exp Res. 18(6):1416-22. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Collins LM. Graham JW. Rousculp SS. Fidler PL. Pan J. Hansen WB. Latent transition analysis and how it can address prevention research questions. 1994. NIDA Res Monogr. 142:81-111. National Institute on Drug Abuse McClearn GE. Jones B. Blizard DA. Plomin R. The utilization of quantitative trait loci in toxicogenetics. 1993 Sep. J Exp Anim Sci. 35(5-6):251-8. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Plomin R. McClearn GE. Quantitative trait loci (QTL) analyses and alcohol-related behaviors. 1993 Mar. Behav Genet. 23(2):197-211. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Vrana SL. Dworkin SI. Vrana KE. Radioenzymatic assay for tryptophan hydroxylase: [3H]H2O release assessed by charcoal adsorption. 1993 Jun. J Neurosci Methods. 48(1-2):123-9. National Institute of General Medical Sciences National Institute on Drug Abuse Vrana SL. Vrana KE. Koves TR. Smith JE. Dworkin SI. Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. 1993 Dec. J Neurochem. 61(6):2262-8. National Institute on Drug Abuse National Institute of General Medical Sciences Morse AC. Erwin VG. Jones BC. Strain and housing affect cocaine self-selection and open-field locomotor activity in mice. 1993 Aug. Pharmacol Biochem Behav. 45(4):905-12. National Institute on Drug Abuse Jones BC. Reed CL. Radcliffe RA. Erwin VG. Pharmacogenetics of cocaine: I. Locomotor activity and self-selection. 1993 Aug. Pharmacogenetics. 3(4):182-8. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Blizard DA. Recombinant-inbred strains: general methodological considerations relevant to the study of complex characters. 1992 Nov. Behav Genet. 22(6):621-33. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Blizard DA. Recombinant-inbred strains: application to behavioral phenomena. 1992 Nov. Behav Genet. 22(6):615-9. National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Streufert S. Pogash RM. Roache J. Gingrich D. Landis R. Severs W. Lonardi L. Kantner A. Effects of alcohol intoxication on risk taking, strategy, and error rate in visuomotor performance. 1992 Aug. J Appl Psychol. 77(4):515-24. National Institute on Drug Abuse McEchron MD. Gormezano I. Morphine's effects on differential serial compound conditioning and reflex modification of the rabbit's (Oryctolagus cuniculus) nictitating membrane response. 1991 Aug. Behav Neurosci. 105(4):510-20. National Institute on Drug Abuse Balaban CD. Henry RT. Zonal organization of olivo-nodulus projections in albino rabbits. 1988 Jun. Neurosci Res. 5(5):409-23. National Institute on Drug Abuse National Institute of Neurological Disorders and Stroke Kamata K. Wilson RL. Alloway KD. Rebec GV. Multiple amphetamine injections reduce the release of ascorbic acid in the neostriatum of the rat. 1986 Jan 8. Brain Res. 362(2):331-8. National Institute on Drug Abuse National Center for Research Resources Veldhuis JD. Evans WS. Demers LM. Thorner MO. Wakat D. Rogol AD. Altered neuroendocrine regulation of gonadotropin secretion in women distance runners. 1985 Sep. J Clin Endocrinol Metab. 61(3):557-63. National Institute of Child Health and Human Development National Institute on Drug Abuse Rebec GV. Centore JM. White LK. Alloway KD. Ascorbic acid and the behavioral response to haloperidol: implications for the action of antipsychotic drugs. 1985 Jan 25. Science. 227(4685):438-40. National Institute on Drug Abuse Wilmore DW. Souba WW. Bessey PQ. Aoki TT. Smith RJ. Pathophysiology of trauma. 1985. Acta Chir Scand Suppl. 522:25-43. National Institute on Drug Abuse Alloway KD. Rebec GV. Apomorphine-induced inhibition of neostriatal activity is enhanced by lesions induced by 6-hydroxydopamine but not by long-term administration of amphetamine. 1984 Sep. Neuropharmacology. 23(9):1033-9. National Institute on Drug Abuse Zagon IS. McLaughlin PJ. Opioids alter tumor cell growth and differentiation in vitro. 1984 Mar. NIDA Res Monogr. 49:344-50. National Institute on Drug Abuse McCormick GY. White WJ. Zagon IS. Lang CM. Effects of diazepam on arterial blood gas concentrations and pH of adult rats acutely and chronically exposed to methadone. 1984 Aug. J Pharmacol Exp Ther. 230(2):353-9. National Institute on Drug Abuse National Center for Research Resources Zagon IS. McLaughlin PJ. Seely JE. Hoeksema GW. Pegg AE. Autoradiographic localization of ornithine decarboxylase in mouse kidney by use of radiolabeled alpha-difluoromethylornithine. 1984. Cell Tissue Res. 235(2):371-7. National Cancer Institute National Institute on Drug Abuse Rebec GV. Gelman J. Alloway KD. Bashore TR. Cataleptogenic potency of the antipsychotic drugs is inversely correlated with neuronal activity in the amygdaloid complex of the rat. 1983 Nov. Pharmacol Biochem Behav. 19(5):759-63. National Institute on Drug Abuse Thompson CI. Zagon IS. Reduced social dominance in rats perinatally exposed to methadone. 1983 Jan-Feb. Neurobehav Toxicol Teratol. 5(1):17-21. National Institute on Drug Abuse Ewing AG. Alloway KD. Curtis SD. Dayton MA. Wightman RM. Rebec GV. Simultaneous electrochemical and unit recording measurements: characterization of the effects of D-amphetamine and ascorbic acid on neostriatal neurons. 1983 Feb 14. Brain Res. 261(1):101-8. National Institute of Neurological Disorders and Stroke National Institute on Drug Abuse Alloway KD. Rebec GV. Shift from inhibition to excitation in the neostriatum but not in the nucleus accumbens following long-term amphetamine. 1983 Aug 22. Brain Res. 273(1):71-9. National Institute on Drug Abuse Zagon IS. McLaughlin PJ. Somatic and neurobiological alterations in the progeny of female rats treated with methadone prior to mating. 1983 Apr. NIDA Res Monogr. 43:184-9. National Institute on Drug Abuse Zagon IS. McLaughlin PJ. Behavioral effects of prenatal exposure to opiates. 1983. Monogr Neural Sci. 9:159-68. National Institute on Drug Abuse Zagon IS. McLaughlin PJ. Neuronal cell deficits following exposure to methadone in rats. 1982 Oct 15. Experientia. 38(10):1214-6. National Institute on Drug Abuse Zagon IS. McLaughlin PJ. Analgesia in young and adult rats perinatally exposed to methadone. 1982 Jul-Aug. Neurobehav Toxicol Teratol. 4(4):455-7. National Institute on Drug Abuse Pegg AE. Seely J. Zagon IS. Autoradiographic identification of ornithine decarboxylase in mouse kidney by means of alpha-[5-14C]difluoromethylornithine. 1982 Jul 2. Science. 217(4554):68-70. National Heart, Lung, and Blood Institute National Cancer Institute National Institute on Drug Abuse Zagon IS. McLaughlin PJ. Effect of chronic heroin exposure on pregnant rats and their offspring. 1982 Apr. NIDA Res Monogr. 41:488-94. National Institute on Drug Abuse Zagon IS. McLaughlin PJ. Comparative effects of postnatal undernutrition and methadone exposure on protein and nucleic acid contents of the brain and cerebellum in rats. 1982. Dev Neurosci. 5(5-6):385-93. National Institute on Drug Abuse Zagon IS. McLaughlin PJ. Weaver DJ. Zagon E. Opiates, endorphins and the developing organism: a comprehensive bibliography. 1982. Neurosci Biobehav Rev. 6(4):439-79. National Institute on Drug Abuse Zagon IS. Haring JH. Protargol silver impregnation and neuronal selectivity. Light and electron microscopic observations. 1982. Acta Anat (Basel). 114(3):193-210. National Cancer Institute National Institute on Drug Abuse Thompson CI. Zagon IS. Long-term thermoregulatory changes following perinatal methadone exposure in rats. 1981 May. Pharmacol Biochem Behav. 14(5):653-9. National Institute on Drug Abuse Zagon IS. McLaughlin PJ. Naloxone prolongs the survival time of mice treated with neuroblastoma. 1981 Mar 9. Life Sci. 28(10):1095-102. National Cancer Institute National Institute on Drug Abuse Zagon IS. McLaughlin PJ. Heroin prolongs survival time and retards tumor growth in mice with neuroblastoma. 1981 Jul. Brain Res Bull. 7(1):25-32. National Cancer Institute National Institute on Drug Abuse Rebec GV. Alloway KD. Bashore TR. Differential actions of classical and atypical antipsychotic drugs on spontaneous neuronal activity in the amygdaloid complex. 1981 Jan. Pharmacol Biochem Behav. 14(1):49-56. National Institute on Drug Abuse Zagon IS. The effect of heroin and naloxone on the growth of neuroblastoma tumors in mice. 1981 Feb. NIDA Res Monogr. 34:394-8. National Institute on Drug Abuse Zagon IS. McLaughlin PJ. Withdrawal-like symptoms in young and adult rats maternally exposed to methadone. 1981 Dec. Pharmacol Biochem Behav. 15(6):887-94. National Institute on Drug Abuse Thompson CI. Zagon IS. 2-Deoxy-D-glucose produces delayed hypophagia and conditioned taste aversion in rats. 1981 Dec. Physiol Behav. 27(6):1001-4. National Institute on Drug Abuse Rebec GV. Alloway KD. Curtis SD. Apparent serotonergic modulation of the dose-dependent biphasic response of neostriatal neurons produced by D-amphetamine. 1981 Apr 6. Brain Res. 210(1-2):277-89. National Institute on Drug Abuse Uhde TW. Redmond DE. Kleber HD. Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study. 1980 Mar. Psychiatry Res. 2(1):37-47. National Institute on Drug Abuse National Institute of Mental Health Rebec GV. Bashore TR. Zimmerman KS. Alloway KD. Neostriatal and mesolimbic neurons: dose-dependent effects of clozapine. 1980 Mar. Neuropharmacology. 19(3):281-8. National Institute on Drug Abuse McLaughlin PJ. Zagon IS. Body and organ development of young rats maternally exposed to methadone. 1980. Biol Neonate. 38(3-4):185-96. National Institute on Drug Abuse